Observational studyBMC women's health2026
GyneFix levonorgestrel-releasing intrauterine system for Chinese patients: a preliminary retrospective self-controlled observational study.
Observational study in BMC women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundDevice expulsion is a common complication of the levonorgestrel-releasing intrauterine system (LNG-IUS), with a higher incidence among high-risk patients presenting with enlarged uterine cavities, cervical laxity or menorrhagia. At present, no commercially available frameless LNG-IUS is marketed in mainland China, leaving these high-risk patients without effective clinical interventions.
objectivesThis study describes the assembly procedures and clinical application of a modified frameless LNG-IUS based on the GyneFix anchoring system (GyneFix-LNG-IUS), and the intrauterine retention performance is preliminarily assessed alongside its capacity to reduce expulsion risk.
methodsThis was a retrospective, self-controlled, observational prognostic study. A total of 15 consecutive cases were included. All included cases had a documented history of conventional LNG-IUS expulsion and multiple high-risk factors for expulsion, including enlarged uterine cavities, menorrhagia and cervical laxity. The modified device was assembled using the GyneFix anchoring component and a standard LNG-IUS, and inserted under hysteroscopic guidance. The 12-month device retention rate and its corresponding 95% confidence interval were calculated.
resultsAll insertions of GyneFix-LNG-IUS were completed successfully in a single attempt, and no intra-operative or post-operative complications were recorded. Gynaecological ultrasound data acquired at 12 months or longer after placement were collected for all cases. Ultrasonographic examinations confirmed that all devices were positioned within the uterine fundus, with no signs of downward displacement or expulsion observed. The 12-month retention rate was 100% (95% CI: 78.2%-100%).
conclusionsBased on the limited data from this small cohort, the modified GyneFix-LNG-IUS features simple assembly and smooth intrauterine insertion. Preliminary findings indicate that this device may reduce expulsion risk among patients prone to conventional LNG-IUS loss. It may serve as a viable clinical alternative in settings without access to commercial frameless LNG-IUS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.